Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	metallopeptidase activity	MBTPS1 NAALAD2 AEBP1 PAPPA LTA4H MMP9 PRPF8	1.21e-05	200	77	7	GO:0008237
GeneOntologyMolecularFunction	acetylcholinesterase activity	ACHE BCHE	1.47e-05	2	77	2	GO:0003990
GeneOntologyMolecularFunction	cholinesterase activity	ACHE BCHE	4.39e-05	3	77	2	GO:0004104
GeneOntologyMolecularFunction	collagen binding	AEBP1 ACHE MMP9 PCOLCE	2.72e-04	81	77	4	GO:0005518
GeneOntologyMolecularFunction	choline binding	ACHE BCHE	3.04e-04	7	77	2	GO:0033265
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH3 DNAH10 HTT	3.90e-04	37	77	3	GO:0045505
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	CCZ1B LLGL2 RASA1 KALRN MYCBP2 CCZ1 RAB3GAP2 DEPDC1	7.41e-04	507	77	8	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	CCZ1B LLGL2 RASA1 KALRN MYCBP2 CCZ1 RAB3GAP2 DEPDC1	7.41e-04	507	77	8	GO:0030695
GeneOntologyBiologicalProcess	choline metabolic process	ACHE BCHE ALDH7A1	2.45e-06	8	74	3	GO:0019695
GeneOntologyBiologicalProcess	acetylcholine catabolic process	ACHE BCHE	3.80e-05	3	74	2	GO:0006581
GeneOntologyBiologicalProcess	cell junction organization	UNC13B NPHS1 SDK2 NRCAM KALRN MYCBP2 ACHE SLITRK4 MTSS1 GJC1 DAG1 NBEA CNTN6	3.85e-05	974	74	13	GO:0034330
GeneOntologyBiologicalProcess	axon guidance	NRCAM KALRN PTPRM MYCBP2 LAMA1 DAG1 CNTN6	7.29e-05	285	74	7	GO:0007411
GeneOntologyBiologicalProcess	neuron projection guidance	NRCAM KALRN PTPRM MYCBP2 LAMA1 DAG1 CNTN6	7.45e-05	286	74	7	GO:0097485
GeneOntologyBiologicalProcess	regulation of neurotransmitter receptor localization to postsynaptic specialization membrane	KALRN DAG1 NBEA	9.63e-05	25	74	3	GO:0098696
GeneOntologyBiologicalProcess	spermatogonial cell division	ZNF449 DICER1	1.26e-04	5	74	2	GO:0007284
GeneOntologyBiologicalProcess	neuron projection morphogenesis	NRCAM KALRN PTPRM MYCBP2 ACHE SLITRK4 LAMA1 IMPACT DAG1 DICER1 CNTN6	1.28e-04	802	74	11	GO:0048812
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	NRCAM KALRN PTPRM MYCBP2 ACHE SLITRK4 LAMA1 IMPACT DAG1 DICER1 CNTN6	1.54e-04	819	74	11	GO:0120039
GeneOntologyBiologicalProcess	synapse organization	UNC13B SDK2 NRCAM KALRN MYCBP2 ACHE SLITRK4 DAG1 NBEA CNTN6	1.61e-04	685	74	10	GO:0050808
GeneOntologyBiologicalProcess	cell projection morphogenesis	NRCAM KALRN PTPRM MYCBP2 ACHE SLITRK4 LAMA1 IMPACT DAG1 DICER1 CNTN6	1.66e-04	826	74	11	GO:0048858
GeneOntologyBiologicalProcess	axonogenesis	NRCAM KALRN PTPRM MYCBP2 ACHE SLITRK4 LAMA1 DAG1 CNTN6	1.87e-04	566	74	9	GO:0007409
GeneOntologyBiologicalProcess	interleukin-17A-mediated signaling pathway	TRAF3IP2 IL17RC	1.89e-04	6	74	2	GO:0038173
GeneOntologyBiologicalProcess	ammonium ion metabolic process	ACHE BCHE ALDH7A1	2.04e-04	32	74	3	GO:0097164
GeneOntologyBiologicalProcess	regulation of protein localization to synapse	KALRN DAG1 NBEA	3.42e-04	38	74	3	GO:1902473
GeneOntologyBiologicalProcess	acetate ester metabolic process	ACHE BCHE	3.51e-04	8	74	2	GO:1900619
GeneOntologyBiologicalProcess	acetylcholine metabolic process	ACHE BCHE	3.51e-04	8	74	2	GO:0008291
GeneOntologyBiologicalProcess	regulation of receptor localization to synapse	KALRN DAG1 NBEA	3.69e-04	39	74	3	GO:1902683
GeneOntologyBiologicalProcess	axon development	NRCAM KALRN PTPRM MYCBP2 ACHE SLITRK4 LAMA1 DAG1 CNTN6	4.72e-04	642	74	9	GO:0061564
GeneOntologyCellularComponent	collagen-containing extracellular matrix	NPHS1 AEBP1 ACHE LAMA1 DAG1 MMP9 ZP4 PLSCR1 PCOLCE	1.27e-04	530	76	9	GO:0062023
GeneOntologyCellularComponent	Mon1-Ccz1 complex	CCZ1B CCZ1	1.30e-04	5	76	2	GO:0035658
GeneOntologyCellularComponent	synaptic membrane	UNC13B SHISA9 CADM3 NRCAM ACHE DAG1 NBEA CNTN6 HTT	2.59e-04	583	76	9	GO:0097060
GeneOntologyCellularComponent	inner dynein arm	DNAH3 DNAH10	5.76e-04	10	76	2	GO:0036156
GeneOntologyCellularComponent	extracellular matrix	NPHS1 AEBP1 ACHE LAMA1 DAG1 MMP9 ZP4 PLSCR1 PCOLCE	6.11e-04	656	76	9	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	NPHS1 AEBP1 ACHE LAMA1 DAG1 MMP9 ZP4 PLSCR1 PCOLCE	6.24e-04	658	76	9	GO:0030312
GeneOntologyCellularComponent	basement membrane	NPHS1 ACHE LAMA1 DAG1	1.02e-03	122	76	4	GO:0005604
GeneOntologyCellularComponent	cell-cell junction	NPHS1 CADM3 LLGL2 PTPRM MTSS1 LAMA1 GJC1 DAG1	1.36e-03	591	76	8	GO:0005911
Domain	DUF1712	CCZ1B CCZ1	1.42e-05	2	71	2	PF08217
Domain	AChE_tetra	ACHE BCHE	1.42e-05	2	71	2	PF08674
Domain	Cholinesterase	ACHE BCHE	1.42e-05	2	71	2	IPR000997
Domain	DUF1088	NBEA LRBA	1.42e-05	2	71	2	IPR010508
Domain	DUF1712_fun	CCZ1B CCZ1	1.42e-05	2	71	2	IPR013176
Domain	AChE_tetra	ACHE BCHE	1.42e-05	2	71	2	PD415333
Domain	DUF1088	NBEA LRBA	1.42e-05	2	71	2	PF06469
Domain	AChE_tetra	ACHE BCHE	1.42e-05	2	71	2	IPR014788
Domain	Galactose-bd-like	AEBP1 PTPRM MYCBP2 LAMA1 GLB1L2	2.91e-05	94	71	5	IPR008979
Domain	-	CLGN LAMA1 PAPPA NBEA LRBA	3.06e-05	95	71	5	2.60.120.200
Domain	IGc2	NPHS1 CADM3 SDK2 NRCAM KALRN MCAM CNTN6	3.06e-05	235	71	7	SM00408
Domain	Ig_sub2	NPHS1 CADM3 SDK2 NRCAM KALRN MCAM CNTN6	3.06e-05	235	71	7	IPR003598
Domain	fn3	NPHS1 SDK2 NRCAM KALRN PTPRM CNTN6	3.49e-05	162	71	6	PF00041
Domain	Ig-like_fold	NPHS1 CADM3 SDK2 NRCAM KALRN PTPRM MYCBP2 MCAM DAG1 IGKV4-1 CNTN6	6.75e-05	706	71	11	IPR013783
Domain	FN3	NPHS1 SDK2 NRCAM KALRN PTPRM CNTN6	7.31e-05	185	71	6	SM00060
Domain	Ig_I-set	NPHS1 CADM3 SDK2 NRCAM KALRN CNTN6	8.47e-05	190	71	6	IPR013098
Domain	I-set	NPHS1 CADM3 SDK2 NRCAM KALRN CNTN6	8.47e-05	190	71	6	PF07679
Domain	IG_LIKE	NPHS1 CADM3 SDK2 NRCAM KALRN PTPRM MCAM IGKV4-1 CNTN6	9.77e-05	491	71	9	PS50835
Domain	FN3	NPHS1 SDK2 NRCAM KALRN PTPRM CNTN6	1.09e-04	199	71	6	PS50853
Domain	Ig-like_dom	NPHS1 CADM3 SDK2 NRCAM KALRN PTPRM MCAM IGKV4-1 CNTN6	1.17e-04	503	71	9	IPR007110
Domain	DUF4704	NBEA LRBA	1.41e-04	5	71	2	IPR031570
Domain	DUF4704	NBEA LRBA	1.41e-04	5	71	2	PF15787
Domain	FN3_dom	NPHS1 SDK2 NRCAM KALRN PTPRM CNTN6	1.43e-04	209	71	6	IPR003961
Domain	ConA-like_dom	CLGN PTPRM LAMA1 PAPPA NBEA LRBA	1.84e-04	219	71	6	IPR013320
Domain	IG	NPHS1 CADM3 SDK2 NRCAM KALRN PTPRM MCAM CNTN6	1.92e-04	421	71	8	SM00409
Domain	Ig_sub	NPHS1 CADM3 SDK2 NRCAM KALRN PTPRM MCAM CNTN6	1.92e-04	421	71	8	IPR003599
Domain	-	NPHS1 CADM3 SDK2 NRCAM KALRN PTPRM MYCBP2 MCAM DAG1 CNTN6	1.94e-04	663	71	10	2.60.40.10
Domain	SEFIR	TRAF3IP2 IL17RC	2.12e-04	6	71	2	PF08357
Domain	SEFIR_dom	TRAF3IP2 IL17RC	2.12e-04	6	71	2	IPR013568
Domain	PH_BEACH	NBEA LRBA	2.12e-04	6	71	2	PF14844
Domain	SEFIR	TRAF3IP2 IL17RC	2.12e-04	6	71	2	PS51534
Domain	PH-BEACH_dom	NBEA LRBA	3.93e-04	8	71	2	IPR023362
Domain	-	NBEA LRBA	3.93e-04	8	71	2	2.30.29.40
Domain	PH_BEACH	NBEA LRBA	3.93e-04	8	71	2	PS51783
Domain	Carboxylesterase_B_AS	ACHE BCHE	3.93e-04	8	71	2	IPR019826
Domain	CARBOXYLESTERASE_B_1	ACHE BCHE	3.93e-04	8	71	2	PS00122
Domain	PAZ	PIWIL1 DICER1	5.04e-04	9	71	2	PS50821
Domain	BEACH_dom	NBEA LRBA	5.04e-04	9	71	2	IPR000409
Domain	PAZ	PIWIL1 DICER1	5.04e-04	9	71	2	SM00949
Domain	BEACH	NBEA LRBA	5.04e-04	9	71	2	PS50197
Domain	Beach	NBEA LRBA	5.04e-04	9	71	2	PF02138
Domain	-	NBEA LRBA	5.04e-04	9	71	2	1.10.1540.10
Domain	Beach	NBEA LRBA	5.04e-04	9	71	2	SM01026
Domain	PAZ_dom	PIWIL1 DICER1	5.04e-04	9	71	2	IPR003100
Domain	PAZ	PIWIL1 DICER1	5.04e-04	9	71	2	PF02170
Domain	C2-set_2	NPHS1 CADM3 MCAM	5.06e-04	41	71	3	PF08205
Domain	CD80_C2-set	NPHS1 CADM3 MCAM	5.06e-04	41	71	3	IPR013162
Domain	ig	NPHS1 SDK2 NRCAM PTPRM MCAM	7.82e-04	190	71	5	PF00047
Domain	Immunoglobulin	NPHS1 SDK2 NRCAM PTPRM MCAM	7.82e-04	190	71	5	IPR013151
Domain	Carboxylesterase_B_CS	ACHE BCHE	1.08e-03	13	71	2	IPR019819
Domain	Dynein_heavy_chain_D4_dom	DNAH3 DNAH10	1.26e-03	14	71	2	IPR024317
Domain	Dynein_HC_stalk	DNAH3 DNAH10	1.26e-03	14	71	2	IPR024743
Domain	CARBOXYLESTERASE_B_2	ACHE BCHE	1.26e-03	14	71	2	PS00941
Domain	Dynein_heavy_dom-2	DNAH3 DNAH10	1.26e-03	14	71	2	IPR013602
Domain	DHC_N2	DNAH3 DNAH10	1.26e-03	14	71	2	PF08393
Domain	MT	DNAH3 DNAH10	1.26e-03	14	71	2	PF12777
Domain	AAA_8	DNAH3 DNAH10	1.26e-03	14	71	2	PF12780
Domain	ATPase_dyneun-rel_AAA	DNAH3 DNAH10	1.26e-03	14	71	2	IPR011704
Domain	COesterase	ACHE BCHE	1.26e-03	14	71	2	PF00135
Domain	CarbesteraseB	ACHE BCHE	1.26e-03	14	71	2	IPR002018
Domain	AAA_5	DNAH3 DNAH10	1.26e-03	14	71	2	PF07728
Domain	DHC_fam	DNAH3 DNAH10	1.45e-03	15	71	2	IPR026983
Domain	Dynein_heavy_dom	DNAH3 DNAH10	1.45e-03	15	71	2	IPR004273
Domain	Dynein_heavy	DNAH3 DNAH10	1.45e-03	15	71	2	PF03028
Domain	-	AEBP1 MYCBP2 GLB1L2	2.71e-03	73	71	3	2.60.120.260
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	CADM3 NRCAM KALRN PTPRM MCAM CNTN6	2.43e-06	162	82	6	25826454
Pubmed	The DNA sequence and analysis of human chromosome 13.	PRR20C PRR20D PRR20B MYCBP2 PRR20E PRR20A	3.21e-06	170	82	6	15057823
Pubmed	Lack of mutation of DICER1 and FOXL2 genes in microcystic stromal tumor of the ovary.	FOXL2 DICER1	5.49e-06	2	82	2	27830327
Pubmed	The COOH-terminal domain of huntingtin interacts with RhoGEF kalirin and modulates cell survival.	KALRN HTT	5.49e-06	2	82	2	29789657
Pubmed	Cholinesterase homozygous genotype as susceptible biomarker of hypertriglyceridaemia for pesticide-exposed agricultural workers.	ACHE BCHE	5.49e-06	2	82	2	33617373
Pubmed	Molecular cloning of mouse acetylcholinesterase: tissue distribution of alternatively spliced mRNA species.	ACHE BCHE	5.49e-06	2	82	2	2400605
Pubmed	Doxycycline inhibits matrix metalloproteinase-9 and laminin degradation after transient global cerebral ischemia.	LAMA1 MMP9	5.49e-06	2	82	2	19200854
Pubmed	Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: implication in peripheral inflammation.	ACHE BCHE	5.49e-06	2	82	2	29358722
Pubmed	Low Plasma Cholinesterase Activity is Associated With Postoperative Delirium After Noncardiac Surgery in Elderly Patients: AProspective Observational Study.	ACHE BCHE	5.49e-06	2	82	2	30093245
Pubmed	Enzymatic processing of beta-dystroglycan recombinant ectodomain by MMP-9: identification of the main cleavage site.	DAG1 MMP9	5.49e-06	2	82	2	19946898
Pubmed	MIWI associates with translational machinery and PIWI-interacting RNAs (piRNAs) in regulating spermatogenesis.	PIWIL1 DICER1	5.49e-06	2	82	2	16938833
Pubmed	Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell Tumors.	FOXL2 DICER1	5.49e-06	2	82	2	32910017
Pubmed	Correlation of plasma butyrylcholinesterase concentration with Acethylcholinesterase H353N polymorphism in the inflammatory response of Chagas disease patients.	ACHE BCHE	5.49e-06	2	82	2	32006676
Pubmed	Activity of cholinesterases in a young and healthy middle-European population: Relevance for toxicology, pharmacology and clinical praxis.	ACHE BCHE	5.49e-06	2	82	2	28465191
Pubmed	Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity.	ACHE BCHE	5.49e-06	2	82	2	17212694
Pubmed	Cholinesterase activities and biochemical determinations in patients with prostate cancer: influence of Gleason score, treatment and bone metastasis.	ACHE BCHE	5.49e-06	2	82	2	22560633
Pubmed	Differential distribution of butyrylcholinesterase and acetylcholinesterase in the human thalamus.	ACHE BCHE	5.49e-06	2	82	2	12811800
Pubmed	Analysis of cholinesterases in human prostate and sperm: implications in cancer and fertility.	ACHE BCHE	5.49e-06	2	82	2	20356562
Pubmed	Peripheral site and acyl pocket define selective inhibition of mouse butyrylcholinesterase by two biscarbamates.	ACHE BCHE	5.49e-06	2	82	2	23219600
Pubmed	Pharmacophore-based virtual screening and molecular docking to identify promising dual inhibitors of human acetylcholinesterase and butyrylcholinesterase.	ACHE BCHE	5.49e-06	2	82	2	32705955
Pubmed	Huntingtin-associated protein 1 (HAP1) binds to a Trio-like polypeptide, with a rac1 guanine nucleotide exchange factor domain.	KALRN HTT	5.49e-06	2	82	2	9285789
Pubmed	Calcium-activated butyrylcholinesterase in human skin protects acetylcholinesterase against suicide inhibition by neurotoxic organophosphates.	ACHE BCHE	5.49e-06	2	82	2	17335779
Pubmed	Low preoperative plasma cholinesterase activity as a risk marker of postoperative delirium in elderly patients.	ACHE BCHE	5.49e-06	2	82	2	21576115
Pubmed	Cholinesterases are down-expressed in human colorectal carcinoma.	ACHE BCHE	5.49e-06	2	82	2	16909200
Pubmed	Localization of butyrylcholinesterase at the neuromuscular junction of normal and acetylcholinesterase knockout mice.	ACHE BCHE	5.49e-06	2	82	2	20805581
Pubmed	Comparison of polyethylene glycol-conjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds.	ACHE BCHE	5.49e-06	2	82	2	16801396
Pubmed	Dystroglycan binding to laminin alpha1LG4 module influences epithelial morphogenesis of salivary gland and lung in vitro.	LAMA1 DAG1	5.49e-06	2	82	2	11798066
Pubmed	Naturally occurring variations in the human cholinesterase genes: heritability and association with cardiovascular and metabolic traits.	ACHE BCHE	5.49e-06	2	82	2	21493754
Pubmed	Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.	ACHE BCHE	5.49e-06	2	82	2	14622273
Pubmed	IL-17A Recruits Rab35 to IL-17R to Mediate PKCα-Dependent Stress Fiber Formation and Airway Smooth Muscle Contractility.	TRAF3IP2 IL17RC	5.49e-06	2	82	2	30683702
Pubmed	Acetyl- and butyrylcholinesterase activities decrease in human colon adenocarcinoma.	ACHE BCHE	5.49e-06	2	82	2	17192624
Pubmed	Amplification and deletion of the ACHE and BCHE cholinesterase genes in sporadic breast cancer.	ACHE BCHE	5.49e-06	2	82	2	20193849
Pubmed	Rational design of a drug for Alzheimer's disease with cholinesterase inhibitory and neuroprotective activity.	ACHE BCHE	5.49e-06	2	82	2	18457821
Pubmed	Urinary Matrix Metalloproteinase-9 and Nephrin in Idiopathic Membranous Nephropathy: A Cross-Sectional Study.	NPHS1 MMP9	5.49e-06	2	82	2	34707724
Pubmed	Variation of the butyrylcholinesterase (BChE) and acetylcholinesterase (AChE) genes in coronary artery disease.	ACHE BCHE	5.49e-06	2	82	2	21473860
Pubmed	Antidepressants inhibit human acetylcholinesterase and butyrylcholinesterase activity.	ACHE BCHE	5.49e-06	2	82	2	12009429
Pubmed	Activity of acetylcholinesterase and unspecific cholinesterase during differentiation of somites in mouse embryos.	ACHE BCHE	5.49e-06	2	82	2	8651510
Pubmed	Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.	ACHE BCHE	5.49e-06	2	82	2	17194517
Pubmed	Interaction of acetylcholinesterase with the G4 domain of the laminin alpha1-chain.	ACHE LAMA1	5.49e-06	2	82	2	18215127
Pubmed	Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) Commonly Exhibits Positivity With Sex Cord Markers FOXL2 and SF-1 but Lacks FOXL2 and DICER1 Mutations.	FOXL2 DICER1	5.49e-06	2	82	2	26598979
Pubmed	Binding of laminin alpha1-chain LG4-5 domain to alpha-dystroglycan causes tyrosine phosphorylation of syntrophin to initiate Rac1 signaling.	LAMA1 DAG1	5.49e-06	2	82	2	16475793
Pubmed	Respective roles of the catalytic domains and C-terminal tail peptides in the oligomerization and secretory trafficking of human acetylcholinesterase and butyrylcholinesterase.	ACHE BCHE	5.49e-06	2	82	2	19019080
Pubmed	Bio-Guided Fractionation of Stem Bark Extracts from Phyllanthus muellarianus: Identification of Phytocomponents with Anti-Cholinesterase Activity.	ACHE BCHE	5.49e-06	2	82	2	34299650
Pubmed	Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol.	ACHE BCHE	5.49e-06	2	82	2	18167304
Pubmed	DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.	FOXL2 DICER1	5.49e-06	2	82	2	26033501
Pubmed	Discovery of novel 2,6-disubstituted pyridazinone derivatives as acetylcholinesterase inhibitors.	ACHE BCHE	5.49e-06	2	82	2	23466605
Pubmed	Expression of cholinesterases in human kidney and its variation in renal cell carcinoma types.	ACHE BCHE	5.49e-06	2	82	2	20883446
Pubmed	Naturally Occurring Genetic Variants of Human Acetylcholinesterase and Butyrylcholinesterase and Their Potential Impact on the Risk of Toxicity from Cholinesterase Inhibitors.	ACHE BCHE	5.49e-06	2	82	2	27551784
Pubmed	DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.	FOXL2 DICER1	5.49e-06	2	82	2	30986800
Pubmed	The BEACH Protein LRBA Promotes the Localization of the Heterotrimeric G-protein Golf to Olfactory Cilia.	NBEA LRBA	1.64e-05	3	82	2	28814779
Pubmed	Acetylcholinesterase/paraoxonase genotype and expression predict anxiety scores in Health, Risk Factors, Exercise Training, and Genetics study.	ACHE BCHE	1.64e-05	3	82	2	15060281
Pubmed	Non-muscle alpha-dystroglycan is involved in epithelial development.	LAMA1 DAG1	1.64e-05	3	82	2	7790379
Pubmed	Analysis of the expression levels of chemerin, ox-LDL, MMP-9, and PAPP-A in ICVD patients and their relationship with the severity of neurological impairment.	PAPPA MMP9	1.64e-05	3	82	2	35620813
Pubmed	PI3KC3 complex subunit NRBF2 is required for apoptotic cell clearance to restrict intestinal inflammation.	CCZ1B CCZ1	1.64e-05	3	82	2	32160108
Pubmed	Exposure of cryptic domains in the alpha 1-chain of laminin-1 by elastase stimulates macrophages urokinase and matrix metalloproteinase-9 expression.	LAMA1 MMP9	1.64e-05	3	82	2	11827968
Pubmed	The chromatoid body of male germ cells: similarity with processing bodies and presence of Dicer and microRNA pathway components.	PIWIL1 DICER1	1.64e-05	3	82	2	16477042
Pubmed	Variability of AChE, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with Donepezil and Rivastigmine.	ACHE BCHE	1.64e-05	3	82	2	18780301
Pubmed	Potentially functional genetic variants in microRNA processing genes and risk of HBV-related hepatocellular carcinoma.	PIWIL1 DICER1	1.64e-05	3	82	2	23868705
Pubmed	The effects of some porphyrinogenic drugs on the brain cholinergic system.	ACHE BCHE	1.64e-05	3	82	2	11929041
Pubmed	CD146 deficiency aggravates chronic obstructive pulmonary disease via the increased production of S100A9 and MMP-9 in macrophages.	MCAM MMP9	1.64e-05	3	82	2	38109838
Pubmed	MMP2-9 cleavage of dystroglycan alters the size and molecular composition of Schwann cell domains.	DAG1 MMP9	1.64e-05	3	82	2	21865464
Pubmed	Human acetylcholinesterase binds to mouse laminin-1 and human collagen IV by an electrostatic mechanism at the peripheral anionic site.	ACHE LAMA1	1.64e-05	3	82	2	12524166
Pubmed	MIWI prevents aneuploidy during meiosis by cleaving excess satellite RNA.	PIWIL1 DICER1	1.64e-05	3	82	2	32677148
Pubmed	Matrix metalloproteinase-9 mediates post-hypoxic vascular pruning of cerebral blood vessels by degrading laminin and claudin-5.	LAMA1 MMP9	1.64e-05	3	82	2	25812799
Pubmed	Mouse large can modify complex N- and mucin O-glycans on alpha-dystroglycan to induce laminin binding.	LAMA1 DAG1	1.64e-05	3	82	2	15788414
Pubmed	Dystroglycan is a binding protein of laminin and merosin in peripheral nerve.	LAMA1 DAG1	1.64e-05	3	82	2	7925941
Pubmed	Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial-Mesenchymal Transition.	DICER1 EPAS1	1.64e-05	3	82	2	28167508
Pubmed	Laminin alpha1 chain mediated reduction of laminin alpha2 chain deficient muscular dystrophy involves integrin alpha7beta1 and dystroglycan.	LAMA1 DAG1	1.64e-05	3	82	2	16504180
Pubmed	Candidate gene association studies of genes involved in neuronal cholinergic transmission in Alzheimer's disease suggests choline acetyltransferase as a candidate deserving further study.	ACHE BCHE	1.64e-05	3	82	2	15690550
Pubmed	Brain alpha-dystroglycan displays unique glycoepitopes and preferential binding to laminin-10/11.	LAMA1 DAG1	1.64e-05	3	82	2	16709410
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	MBTPS1 CLGN MAN2B2 MYCBP2 SLITRK4 LAMA1 MCAM DAG1 GLB1L2 PLSCR1 HTT PCOLCE	2.43e-05	1201	82	12	35696571
Pubmed	Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.	AEBP1 MCAM DAG1 MMP9 PCOLCE	2.56e-05	146	82	5	27068509
Pubmed	Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.	MAN2B2 AEBP1 LAMA1 DAG1 PAPPA PCOLCE	2.75e-05	248	82	6	24006456
Pubmed	Characterization of the interactions between mammalian PAZ PIWI domain proteins and Dicer.	PIWIL1 DICER1	3.28e-05	4	82	2	14749716
Pubmed	Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.	ACHE BCHE	3.28e-05	4	82	2	16213467
Pubmed	SH3 domain-dependent association of huntingtin with epidermal growth factor receptor signaling complexes.	RASA1 HTT	3.28e-05	4	82	2	9079622
Pubmed	Copy number variation in ACHE/EPHB4 (7q22) and in BCHE/MME (3q26) genes in sporadic breast cancer.	ACHE BCHE	3.28e-05	4	82	2	23063927
Pubmed	Alzheimer's disease: case-control association study of polymorphisms in ACHE, CHAT, and BCHE genes in a Sardinian sample.	ACHE BCHE	3.28e-05	4	82	2	17503475
Pubmed	Molecular recognition by LARGE is essential for expression of functional dystroglycan.	LAMA1 DAG1	3.28e-05	4	82	2	15210115
Pubmed	Identification, tissue specific expression, and chromosomal localisation of several human dynein heavy chain genes.	DNAH3 DNAH10	3.28e-05	4	82	2	11175280
Pubmed	Cleavage of β-dystroglycan occurs in sarcoglycan-deficient skeletal muscle without MMP-2 and MMP-9.	DAG1 MMP9	3.28e-05	4	82	2	28821434
Pubmed	Non-enzymatic developmental functions of acetylcholinesterase--the question of redundancy.	ACHE LAMA1	3.28e-05	4	82	2	18785927
Pubmed	Discovery of potent carbonic anhydrase, acetylcholinesterase, and butyrylcholinesterase enzymes inhibitors: The new amides and thiazolidine-4-ones synthesized on an acetophenone base.	ACHE BCHE	3.28e-05	4	82	2	28544359
Pubmed	Dystroglycan protein distribution coincides with basement membranes and muscle differentiation during mouse embryogenesis.	LAMA1 DAG1	3.28e-05	4	82	2	17676646
Pubmed	Proteolytic processing of secretory pathway kinase Fam20C by site-1 protease promotes biomineralization.	MBTPS1 SEC24A	3.28e-05	4	82	2	34349020
Pubmed	Identification of two evolutionarily conserved genes regulating processing of engulfed apoptotic cells.	CCZ1B CCZ1	3.28e-05	4	82	2	20305638
Pubmed	IL-17A-Induced PLET1 Expression Contributes to Tissue Repair and Colon Tumorigenesis.	TRAF3IP2 IL17RC	5.47e-05	5	82	2	29070673
Pubmed	BCL8 is a novel, evolutionarily conserved human gene family encoding proteins with presumptive protein kinase A anchoring function.	NBEA LRBA	5.47e-05	5	82	2	12160729
Pubmed	Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase.	LAMA1 DAG1	5.47e-05	5	82	2	19587235
Pubmed	Focal MMP-2 and MMP-9 activity at the blood-brain barrier promotes chemokine-induced leukocyte migration.	DAG1 MMP9	5.47e-05	5	82	2	25704809
Pubmed	Genetic risk for restenosis after coronary stenting.	BCHE MMP9	5.47e-05	5	82	2	17275003
Pubmed	L-plastin nanobodies perturb matrix degradation, podosome formation, stability and lifetime in THP-1 macrophages.	MMP9 LCP1	5.47e-05	5	82	2	24236012
Pubmed	Roles of MIWI, MILI and PLD6 in small RNA regulation in mouse growing oocytes.	PIWIL1 DICER1	8.19e-05	6	82	2	28115634
Pubmed	Absence of post-phosphoryl modification in dystroglycanopathy mouse models and wild-type tissues expressing non-laminin binding form of α-dystroglycan.	LAMA1 DAG1	8.19e-05	6	82	2	22270369
Pubmed	IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail.	TRAF3IP2 IL17RC	8.19e-05	6	82	2	20554964
Pubmed	An evolutionarily conserved nested gene pair - Mab21 and Lrba/Nbea in metazoan.	NBEA LRBA	8.19e-05	6	82	2	19482073
Pubmed	Distinct alpha 7A beta 1 and alpha 7B beta 1 integrin expression patterns during mouse development: alpha 7A is restricted to skeletal muscle but alpha 7B is expressed in striated muscle, vasculature, and nervous system.	LAMA1 DAG1	1.14e-04	7	82	2	8950511
Pubmed	Endochondral Ossification Is Accelerated in Cholinesterase-Deficient Mice and in Avian Mesenchymal Micromass Cultures.	ACHE BCHE	1.14e-04	7	82	2	28118357
Pubmed	Site-specific expression of gelatinolytic activity during morphogenesis of the secondary palate in the mouse embryo.	LAMA1 MMP9	1.52e-04	8	82	2	23091646
Pubmed	Cloning and expression analyses of mouse dystroglycan gene: specific expression in maternal decidua at the peri-implantation stage.	LAMA1 DAG1	1.52e-04	8	82	2	8872465
Interaction	ZNF683 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	1.89e-10	10	78	5	int:ZNF683
Interaction	CELF4 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	3.46e-10	11	78	5	int:CELF4
Interaction	BEND2 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	5.91e-10	12	78	5	int:BEND2
Interaction	PTTG2 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	1.49e-09	14	78	5	int:PTTG2
Interaction	MBNL3 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	3.22e-09	16	78	5	int:MBNL3
Interaction	PRR34 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	1.48e-08	21	78	5	int:PRR34
Interaction	TPRX1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	1.48e-08	21	78	5	int:TPRX1
Interaction	DMRT3 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A SPAG8 PLSCR1	4.51e-08	87	78	7	int:DMRT3
Interaction	C3orf36 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	4.71e-08	26	78	5	int:C3orf36
Interaction	ZBTB32 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A SPAG8	9.53e-08	58	78	6	int:ZBTB32
Interaction	ZNF385C interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	1.66e-07	33	78	5	int:ZNF385C
Interaction	HLX interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	3.02e-07	37	78	5	int:HLX
Interaction	ZCCHC14 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	3.02e-07	37	78	5	int:ZCCHC14
Interaction	TBX6 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	5.12e-07	41	78	5	int:TBX6
Interaction	HYPK interactions	PRR20C PRR20D PRR20B PRR20E ZNF516 PRR20A HTT	5.47e-07	125	78	7	int:HYPK
Interaction	FAM222B interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	5.80e-07	42	78	5	int:FAM222B
Interaction	PITX1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A SPAG8 PLSCR1	6.09e-07	127	78	7	int:PITX1
Interaction	SAMD11 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	6.54e-07	43	78	5	int:SAMD11
Interaction	BICRAL interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	6.54e-07	43	78	5	int:BICRAL
Interaction	PRR35 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A SPAG8	8.23e-07	83	78	6	int:PRR35
Interaction	RBPMS2 interactions	PRR20C PRR20D PRR20B MYCBP2 PRR20E PRR20A	8.23e-07	83	78	6	int:RBPMS2
Interaction	SP4 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	9.23e-07	46	78	5	int:SP4
Interaction	KRTAP19-1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	1.03e-06	47	78	5	int:KRTAP19-1
Interaction	VPS37C interactions	PRR20C PRR20D PRR20B PRR20E PRR20A SPAG8 PLSCR1	1.23e-06	141	78	7	int:VPS37C
Interaction	OXER1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	1.41e-06	50	78	5	int:OXER1
Interaction	RIPPLY1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	2.28e-06	55	78	5	int:RIPPLY1
Interaction	FAM9A interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	3.24e-06	59	78	5	int:FAM9A
Interaction	CABP2 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	3.83e-06	61	78	5	int:CABP2
Interaction	PHF1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A SPAG8 DICER1	4.63e-06	172	78	7	int:PHF1
Interaction	LASP1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A SPAG8 PLSCR1 HTT	5.09e-06	247	78	8	int:LASP1
Interaction	C10orf55 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	5.25e-06	65	78	5	int:C10orf55
Interaction	SMAP1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	6.11e-06	67	78	5	int:SMAP1
Interaction	TBX3 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	7.06e-06	69	78	5	int:TBX3
Interaction	ESRP1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	1.21e-05	77	78	5	int:ESRP1
Interaction	YPEL3 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A SPAG8	1.28e-05	133	78	6	int:YPEL3
Interaction	FAM168A interactions	PRR20C PRR20D PRR20B PRR20E PRR20A PLSCR1	1.86e-05	142	78	6	int:FAM168A
Interaction	EPHB2 interactions	RASA1 DNAH10 KALRN MYCBP2 SEC24A LRBA MMP9	2.04e-05	216	78	7	int:EPHB2
Interaction	ARID5A interactions	PRR20C PRR20D PRR20B PRR20E SEC24A PRR20A	2.27e-05	147	78	6	int:ARID5A
Interaction	PRR20B interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	2.59e-05	90	78	5	int:PRR20B
Interaction	PRR20C interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	2.59e-05	90	78	5	int:PRR20C
Interaction	PRR20D interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	2.59e-05	90	78	5	int:PRR20D
Interaction	RBM23 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	3.20e-05	94	78	5	int:RBM23
Interaction	PATZ1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A SPAG8	4.05e-05	163	78	6	int:PATZ1
Interaction	KRTAP19-5 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	4.11e-05	99	78	5	int:KRTAP19-5
Interaction	PRR20E interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	4.52e-05	101	78	5	int:PRR20E
Interaction	TRIM35 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	4.97e-05	103	78	5	int:TRIM35
Interaction	C1orf94 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	4.97e-05	103	78	5	int:C1orf94
Interaction	GTF2A1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	5.20e-05	104	78	5	int:GTF2A1
Interaction	RHOXF2 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	5.20e-05	104	78	5	int:RHOXF2
Interaction	VENTX interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	5.20e-05	104	78	5	int:VENTX
Interaction	VEZF1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	5.44e-05	105	78	5	int:VEZF1
Interaction	GLIS2 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	5.70e-05	106	78	5	int:GLIS2
Interaction	SH3RF1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	6.23e-05	108	78	5	int:SH3RF1
Interaction	TFG interactions	PRR20C PRR20D PRR20B PRR20E SEC24A PRR20A PLSCR1	6.33e-05	258	78	7	int:TFG
Interaction	FOXH1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	6.51e-05	109	78	5	int:FOXH1
Interaction	PRR20A interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	6.51e-05	109	78	5	int:PRR20A
Interaction	NOTCH3 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	7.73e-05	113	78	5	int:NOTCH3
Interaction	DAZAP2 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A PLSCR1	8.44e-05	186	78	6	int:DAZAP2
Interaction	BHLHE40 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	9.87e-05	119	78	5	int:BHLHE40
Interaction	THAP1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	9.87e-05	119	78	5	int:THAP1
Interaction	TCF7L2 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A DICER1 EPAS1	1.18e-04	285	78	7	int:TCF7L2
Interaction	CCNK interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	1.61e-04	132	78	5	int:CCNK
Interaction	SIAH1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A HTT	2.27e-04	223	78	6	int:SIAH1
Interaction	FOXP3 interactions	FOXR1 PRR20C PRR20D PRR20B PRR20E COPB2 PRR20A LCP1	2.64e-04	432	78	8	int:FOXP3
Interaction	POU6F2 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	2.74e-04	148	78	5	int:POU6F2
Interaction	ROR2 interactions	PRR20C PRR20D CLGN PRR20B PRR20E SEC24A PRR20A	3.05e-04	333	78	7	int:ROR2
Interaction	CANX interactions	NPHS1 DNAH3 MBTPS1 CCDC66 CLGN NRCAM DNAH10 PTPRM ACHE SEC24A RAB3GAP2 COPB2 SYPL1 BCHE	3.09e-04	1261	78	14	int:CANX
Interaction	C1orf54 interactions	MBTPS1 MAN2B2 LAMA1 DAG1 BCHE	4.77e-04	167	78	5	int:C1orf54
Interaction	NCK2 interactions	NPHS1 PRR20C PRR20D PRR20B PRR20E PRR20A	5.35e-04	262	78	6	int:NCK2
Interaction	TIAL1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	5.45e-04	172	78	5	int:TIAL1
Interaction	POU2F1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	5.90e-04	175	78	5	int:POU2F1
Interaction	NFYC interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	6.21e-04	177	78	5	int:NFYC
Interaction	BANP interactions	FOXR1 PRR20C PRR20D PRR20B PRR20E PRR20A	7.17e-04	277	78	6	int:BANP
Interaction	PLG interactions	LAMA1 PAPPA MMP9 PCOLCE	7.65e-04	106	78	4	int:PLG
Interaction	HIVEP1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	7.77e-04	186	78	5	int:HIVEP1
Interaction	ABI2 interactions	PRR20C PRR20D PRR20B PRR20E MCAM PRR20A	8.46e-04	286	78	6	int:ABI2
Cytoband	13q21.1	PRR20C PRR20D PRR20B PRR20E PRR20A	2.04e-11	13	82	5	13q21.1
Cytoband	Ensembl 112 genes in cytogenetic band chr13q21	PRR20C PRR20D PRR20B PRR20E PRR20A	2.30e-06	117	82	5	chr13q21
Cytoband	3q23	FOXL2 COPB2 PLSCR1	6.90e-05	44	82	3	3q23
Cytoband	16p13.12	SHISA9 BFAR	1.41e-04	10	82	2	16p13.12
Cytoband	7q22	ACHE PCOLCE	2.12e-03	38	82	2	7q22
Cytoband	7p22.1	CCZ1B CCZ1	3.23e-03	47	82	2	7p22.1
GeneFamily	Fibronectin type III domain containing	NPHS1 SDK2 NRCAM KALRN PTPRM CNTN6	3.48e-06	160	47	6	555
GeneFamily	Immunoglobulin like domain containing	NPHS1 CADM3 SDK2 NRCAM PTPRM MCAM	1.02e-05	193	47	6	594
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	SDK2 NRCAM KALRN PTPRM CNTN6	5.97e-05	161	47	5	593
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	NPHS1 CADM3 MCAM	1.52e-04	40	47	3	592
GeneFamily	WD repeat domain containing\|BEACH domain containing	NBEA LRBA	2.35e-04	9	47	2	1230
GeneFamily	Dyneins, axonemal	DNAH3 DNAH10	8.77e-04	17	47	2	536
GeneFamily	WD repeat domain containing	LLGL2 COPB2 NBEA LRBA	4.71e-03	262	47	4	362
GeneFamily	Forkhead boxes	FOXR1 FOXL2	5.58e-03	43	47	2	508
GeneFamily	Adenosine receptors\|V-set domain containing	NPHS1 CADM3 MCAM	8.73e-03	163	47	3	590
Coexpression	LIM_MAMMARY_STEM_CELL_UP	SDK2 NRCAM AEBP1 MTSS1 LAMA1 MCAM GJC1 EPAS1 PCOLCE	1.02e-05	479	76	9	M2573
Coexpression	LIM_MAMMARY_STEM_CELL_UP	SDK2 NRCAM AEBP1 MTSS1 LAMA1 MCAM GJC1 EPAS1 PCOLCE	1.09e-05	483	76	9	MM1082
Coexpression	KRAS.600.LUNG.BREAST_UP.V1_UP	NPHS1 FOXL2 KIAA1549L NRCAM PIWIL1 MMP9 ZP4	1.72e-05	280	76	7	M2886
Coexpression	GSE23114_WT_VS_SLE2C1_MOUSE_PERITONEAL_CAVITY_B1A_BCELL_UP	RASA1 RAB3GAP2 LAMA1 LTA4H DICER1 PLSCR1	2.16e-05	194	76	6	M8284
Coexpression	GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_DN	NRCAM SDS EPAS1 ALDH7A1 HTT	4.80e-05	136	76	5	M41157
Coexpression	DITTMER_PTHLH_TARGETS_DN	SEC24A MCAM LRBA ALDH7A1	5.18e-05	70	76	4	M18667
Coexpression	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP	PTPRM MCAM LCP1 EPAS1	5.47e-05	71	76	4	M1188
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF449 NAALAD2 ACHE MCAM GJC1 PCOLCE	5.31e-07	167	79	6	b0eb7a40491dd2432f5282f578ce569df86d21a7
ToppCell	droplet-Fat-SCAT-30m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CADM3 KIAA1549L NRCAM AEBP1 PIWIL1 GJC1	7.71e-07	178	79	6	5cf12927f0756c4d8a289fe4308d736382e6212e
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAALAD2 SDK2 NRCAM BCHE ACSS3 PCOLCE	8.23e-07	180	79	6	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	droplet-Limb_Muscle-nan-3m-Macroglial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRCAM PIWIL1 MCAM DAG1 BCHE CNTN6	9.35e-07	184	79	6	da8d6e7944eb35e6cbea2feb7cbc2894787d723f
ToppCell	Frontal_cortex-Endothelial\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	NAALAD2 GJC1 IL17RC PLSCR1 EPAS1 PCOLCE	1.06e-06	188	79	6	a43392dbd10fc7dbfb31be39b8af8a7ea121c894
ToppCell	Globus_pallidus-Endothelial\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	NAALAD2 LLGL2 GJC1 IL17RC PLSCR1 EPAS1	1.09e-06	189	79	6	ad7dc9d25edd68fb624380a082c389fe7d640e7d
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 NRCAM AEBP1 PAPPA ACSS3 PCOLCE	1.09e-06	189	79	6	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 NRCAM AEBP1 PAPPA ACSS3 PCOLCE	1.13e-06	190	79	6	d60395739458d7f47a3350ade751fe3819500320
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 NRCAM AEBP1 PAPPA ACSS3 PCOLCE	1.16e-06	191	79	6	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 NRCAM AEBP1 PAPPA ACSS3 PCOLCE	1.20e-06	192	79	6	f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCell	ILEUM-inflamed-(8)_Pericytes\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	AEBP1 MCAM GJC1 LCP1 EPAS1 PCOLCE	1.39e-06	197	79	6	e04ac8575f66d798ddf2fd6d55d397a163b40732
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF449 CCDC66 LRBA SPAG8 SBK3	8.35e-06	155	79	5	441fcb6d05364fc6f4973f0b973f1a80b573ce1f
ToppCell	Adult-Mesenchymal-myofibroblast_cell\|Adult / Lineage, Cell type, age group and donor	SDK2 NRCAM AEBP1 PAPPA BCHE	1.20e-05	167	79	5	d584a8548a5317bd9686b3be8246ae6ed568796b
ToppCell	frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	AEBP1 LAMA1 PLSCR1 ACSS3 PCOLCE	1.23e-05	168	79	5	9930bd63b60c03f0152838a79eef77da1c2dd8e5
ToppCell	frontal_cortex-Non-neuronal-leptomeningeal_cell\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	AEBP1 LAMA1 PLSCR1 ACSS3 PCOLCE	1.34e-05	171	79	5	2e43fb129ee9bdc3b31febc43c10f959bf0f4a7d
ToppCell	frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	AEBP1 LAMA1 PLSCR1 ACSS3 PCOLCE	1.34e-05	171	79	5	e219a1aa59a96e4bc3e2eacf985679174a51de41
ToppCell	NS-moderate-d_07-13-Lymphoid-NK\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	KIAA1549L NRCAM AEBP1 MCAM GJC1	1.50e-05	175	79	5	f6cd24d22f62469319f9d244e3e5de527d3d4d94
ToppCell	343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	NAALAD2 NRCAM AEBP1 BCHE PCOLCE	1.54e-05	176	79	5	2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b
ToppCell	343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)\|343B / Donor, Lineage, Cell class and subclass (all cells)	NAALAD2 NRCAM AEBP1 BCHE PCOLCE	1.54e-05	176	79	5	f33ab41d121b59d871ad7d48ca021524a027d2ef
ToppCell	primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	AEBP1 LAMA1 PLSCR1 ACSS3 PCOLCE	1.59e-05	177	79	5	599cf7f5b774e197a1b43c98e4b9a8c1a618f38a
ToppCell	COPD-Endothelial-VE_Venous\|World / Disease state, Lineage and Cell class	CADM3 KALRN PTPRM MCAM EPAS1	1.67e-05	179	79	5	9968da1adcb561d9bf167a42ab5d9de85c071c4a
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAALAD2 SDK2 NRCAM BCHE PCOLCE	1.72e-05	180	79	5	9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCell	droplet-Limb_Muscle-nan-3m-Macroglial-Schwann_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIWIL1 MCAM DAG1 BCHE CNTN6	1.86e-05	183	79	5	2cf36ad89584eb9f8b04de52a1b511b7f3527884
ToppCell	droplet-Limb_Muscle-nan-3m-Macroglial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIWIL1 MCAM DAG1 BCHE CNTN6	1.86e-05	183	79	5	98fee6838acfaee5e2e449ba088764ec06b8bc57
ToppCell	COPD-Stromal-Pericyte\|COPD / Disease state, Lineage and Cell class	NRCAM AEBP1 MCAM GJC1 PCOLCE	1.91e-05	184	79	5	a56264a22dfc2d3672b20134ab7c3c7c23da5ae1
ToppCell	moderate-Lymphoid-NK\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	KIAA1549L NRCAM AEBP1 GJC1 PAPPA	1.96e-05	185	79	5	4979a787acbc9b4ca8defe91cc79b674e51af1bf
ToppCell	COPD-Stromal-Pericyte\|World / Disease state, Lineage and Cell class	NRCAM AEBP1 MCAM GJC1 PCOLCE	2.01e-05	186	79	5	8adfd2d1fda4e8aecc95192ea627bf7ed5214b8d
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 NRCAM AEBP1 ACSS3 PCOLCE	2.17e-05	189	79	5	e9d5e858e320c6e9913c1ea6a54967d21eda605f
ToppCell	E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NAALAD2 MCAM GJC1 EPAS1 PCOLCE	2.23e-05	190	79	5	84fbd5664ec886120963d4f50dfa1fd1851d36c1
ToppCell	P07-Mesenchymal-developing_mesenchymal_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NAALAD2 MCAM GJC1 DEPDC1 PCOLCE	2.29e-05	191	79	5	ddbc5f97f2aef19be4ad93db4139876c939b848e
ToppCell	droplet-Fat-Gat-18m-Mesenchymal-Cd34+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHISA9 NAALAD2 AEBP1 PAPPA PCOLCE	2.29e-05	191	79	5	6cab0334f76c973880bd8d1638856f2f6e4a249a
ToppCell	droplet-Fat-Gat-18m-Mesenchymal\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHISA9 NAALAD2 AEBP1 PAPPA PCOLCE	2.29e-05	191	79	5	850c6fff6dc795431ef534fdaa41e4ad50f7367a
ToppCell	droplet-Fat-Gat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHISA9 NAALAD2 AEBP1 PAPPA PCOLCE	2.29e-05	191	79	5	8b2b00202d3c98bccbae1b4a23713892fad0ff23
ToppCell	facs-Marrow-KLS-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCAM GJC1 GLB1L2 EPAS1 PCOLCE	2.34e-05	192	79	5	be75783d9578974b662e1cb13bd3442a921fd50a
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	UNC13B LLGL2 NRCAM LAMA1 GLB1L2	2.34e-05	192	79	5	d3634574b2e8d2ded6446969361b70761b331aea
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 NRCAM AEBP1 PAPPA PCOLCE	2.34e-05	192	79	5	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	LPS-IL1RA-Stromal_mesenchymal\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 NRCAM AEBP1 PAPPA PCOLCE	2.34e-05	192	79	5	4e47a02007f562f29ba5910df64d32a0167d0bd1
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 NRCAM AEBP1 PAPPA PCOLCE	2.34e-05	192	79	5	ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell	facs-Marrow-KLS-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCAM GJC1 GLB1L2 EPAS1 PCOLCE	2.34e-05	192	79	5	4fc98f30f8e738816cd93101fbe8ac40889e302a
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CADM3 KALRN PTPRM MCAM EPAS1	2.40e-05	193	79	5	9ba688b35a9ead5d04691b3f3f15484f02dbbd0d
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-FDC\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NPHS1 PTPRM ACHE PAPPA EPAS1	2.46e-05	194	79	5	f9fbb043411546d8c9e0321a64165d411f44aeb7
ToppCell	metastatic_Brain-Fibroblasts-Pericytes\|metastatic_Brain / Location, Cell class and cell subclass	AEBP1 MCAM GJC1 EPAS1 PCOLCE	2.46e-05	194	79	5	d1889a3e22d5b88461c81ec3ea0e74bb9bf63e60
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAALAD2 SDK2 NRCAM ACSS3 PCOLCE	2.46e-05	194	79	5	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SHISA9 KIAA1549L NRCAM KALRN NBEA	2.59e-05	196	79	5	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	Bronchial-NucSeq-Stromal-Schwann\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHISA9 CADM3 KIAA1549L NRCAM PIWIL1	2.59e-05	196	79	5	a90c76d9c57a4491b94a321ba541b792ec5d8e83
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SHISA9 NRCAM ACHE SLITRK4 BCHE	2.59e-05	196	79	5	f374cb3ec31c6eef2cef9e07547bfd1e380553af
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SHISA9 NRCAM ACHE SLITRK4 BCHE	2.59e-05	196	79	5	671c380b58d7f634b4fbec38c357d357ea4f3535
ToppCell	proximal-mesenchymal-Myofibroblast\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CADM3 AEBP1 PAPPA BCHE PCOLCE	2.65e-05	197	79	5	ab21baea931ff134cf5a7ee369c091230988108b
ToppCell	proximal-mesenchymal-Myofibroblast-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CADM3 AEBP1 PAPPA BCHE PCOLCE	2.65e-05	197	79	5	15f2f169758a07143fc7d1bdb58d0b4d750a0be4
ToppCell	proximal-3-mesenchymal-Myofibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CADM3 AEBP1 PAPPA BCHE PCOLCE	2.65e-05	197	79	5	c59b64674fb4aaa945c1df7e4a9a3605c7cd2b75
ToppCell	Bronchial-NucSeq-Stromal-Schwann-Schwann_nonmyelinating\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHISA9 CADM3 KIAA1549L NRCAM PIWIL1	2.65e-05	197	79	5	4a7ff67bb0754e034e6f2a1bd34cde86ee3ef899
ToppCell	Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	TRAF3IP2 AEBP1 SLITRK4 LAMA1 IL17RC	2.72e-05	198	79	5	0cd930e374c2c48d1991b51c025f9801b22ecee7
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NRCAM KALRN MCAM GJC1 BCHE	2.72e-05	198	79	5	c12e7511628db819a52959bb68580e27c00c2e41
ToppCell	Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	TRAF3IP2 AEBP1 SLITRK4 LAMA1 IL17RC	2.72e-05	198	79	5	e0df6d6ff2a9c41d813f84a2a5ee7cb5f6fc3e30
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CADM3 KIAA1549L KALRN MCAM EPAS1	2.78e-05	199	79	5	3a4deea6e11a0555d27497b7c9983350797aac69
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SDK2 NRCAM MYCBP2 LAMA1 PCOLCE	2.78e-05	199	79	5	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	343B-Fibroblasts-Fibroblast-F\|343B / Donor, Lineage, Cell class and subclass (all cells)	CADM3 AEBP1 PAPPA BCHE PCOLCE	2.78e-05	199	79	5	b877c1d24357249781032e99d4237f72789cc9b8
ToppCell	metastatic_Brain-Fibroblasts\|metastatic_Brain / Location, Cell class and cell subclass	AEBP1 MCAM GJC1 PAPPA PCOLCE	2.78e-05	199	79	5	63eb2106bb6e2e33d020628583536c8d96662c84
ToppCell	distal-3-mesenchymal-Myofibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NRCAM AEBP1 PAPPA BCHE PCOLCE	2.78e-05	199	79	5	1f20addc0d138fec02ed6ca4c518169c568de263
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	NAALAD2 SDK2 NRCAM BCHE PCOLCE	2.78e-05	199	79	5	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	distal-2-mesenchymal-Myofibroblast\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CADM3 AEBP1 PAPPA BCHE PCOLCE	2.78e-05	199	79	5	b8f3cf5bcfde1066bdb49b14fdc842fe9692a6b7
ToppCell	343B-Fibroblasts-Fibroblast-F-\|343B / Donor, Lineage, Cell class and subclass (all cells)	CADM3 AEBP1 PAPPA BCHE PCOLCE	2.78e-05	199	79	5	e32fa66f3361474088ba1dd58574822537950d59
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CADM3 AEBP1 PAPPA BCHE PCOLCE	2.85e-05	200	79	5	0b2614b8513693dd508c9003699049efd9abac52
ToppCell	distal-mesenchymal-Myofibroblast-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NRCAM AEBP1 PAPPA BCHE PCOLCE	2.85e-05	200	79	5	069c8949b33ecfdb6da32992002d4060ff6082bc
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	CADM3 AEBP1 PAPPA BCHE PCOLCE	2.85e-05	200	79	5	8d2ceb2080c67b20f452eeca605aa27a58033c04
ToppCell	distal-mesenchymal-Myofibroblast\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NRCAM AEBP1 PAPPA BCHE PCOLCE	2.85e-05	200	79	5	61854a459385cd9295be37157a8f81a2c227dff3
ToppCell	Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CADM3 NRCAM AEBP1 PAPPA BCHE	2.85e-05	200	79	5	251fd2923f108cd2086961d897244b392c32ad54
ToppCell	cellseq-Mesenchymal-Myocytic-Myocytic_2-SCMF\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NRCAM AEBP1 PAPPA BCHE PCOLCE	2.85e-05	200	79	5	b441b3771fb7d9ee7b7a104afc35e466aace2da2
ToppCell	Parenchyma_COVID-19-Stromal-TX-Fibroblasts-2,_SCARA5\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	CADM3 AEBP1 PAPPA BCHE PCOLCE	2.85e-05	200	79	5	c338a08c1605527ab9aaf62ea151a19e8469dc6d
ToppCell	Pericytes-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	ZNF449 AEBP1 SLITRK4 MCAM	1.47e-04	150	79	4	dbc202bd6db4fb5c8b2abd1200e074a2a9e63a59
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-NP\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	UNC13B DNAH3 LCP1 CNTN6	1.54e-04	152	79	4	b6a7453fbf9f898e4f222b215907c9a110baa2f6
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH3 DNAH10 GLB1L2 SPAG8	1.67e-04	155	79	4	5f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCell	primary_visual_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MCAM GJC1 EPAS1 PCOLCE	1.67e-04	155	79	4	ced64e26962c5c6e6d539f361fe57ab0b399e999
ToppCell	primary_visual_cortex-Non-neuronal-pericyte_cell\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MCAM GJC1 EPAS1 PCOLCE	1.67e-04	155	79	4	0f24ef6486aef354f0911c06932cb01d1a0525ac
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH3 DNAH10 GLB1L2 SPAG8	1.67e-04	155	79	4	0944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCell	primary_visual_cortex-Non-neuronal-pericyte_cell-Peri\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MCAM GJC1 EPAS1 PCOLCE	1.67e-04	155	79	4	d8b5145258f075b15080f8739f537f48dd22225e
ToppCell	Adult-Mesenchymal-myofibroblast_cell-D122\|Adult / Lineage, Cell type, age group and donor	NRCAM AEBP1 PAPPA BCHE	1.79e-04	158	79	4	410fa08c9d880d27e80ec939fa5ba5a41dcb31ab
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	KALRN ACHE MCAM GJC1	1.79e-04	158	79	4	84c0a215dabf697ada036c2b9592d0c61b5077de
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC13B HYAL4 DNAH10 AEBP1	1.79e-04	158	79	4	f296ca24fdedc33f1d24b79e7660763114ce7fa3
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC13B HYAL4 DNAH10 AEBP1	1.79e-04	158	79	4	8c7108f2c40d97a317762ba0b8eca76542b2ebaf
ToppCell	frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LAMA1 PLSCR1 ACSS3 PCOLCE	1.84e-04	159	79	4	34c90711c5857cf6ada7b3acff99f1d48c7caf29
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NAALAD2 MCAM GJC1 PCOLCE	1.93e-04	161	79	4	82ed45f144a07856fe92d37426c5f92e259a03a9
ToppCell	droplet-Kidney-nan-18m-Lymphocytic-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXR1 CLGN MMP9 LCP1	2.07e-04	164	79	4	731b9c7d6f6ecfb14d4a8705e0ddac9fb460d9a8
ToppCell	facs-Kidney-nan-24m-Mesenchymal-mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHISA9 NPHS1 AEBP1 CNTN6	2.12e-04	165	79	4	4cdd80580d5638fd649280ba3893251c2f898f3f
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SHISA9 AEBP1 SLITRK4 PCOLCE	2.12e-04	165	79	4	4e13fccd32029e2879e85f8966e582a46c09e4aa
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NAALAD2 KIAA1549L PTPRM EPAS1	2.12e-04	165	79	4	a74751e0ec857aa974bec04ccc747c004a8f6e01
ToppCell	facs-Kidney-nan-24m-Mesenchymal-mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHISA9 NPHS1 AEBP1 CNTN6	2.12e-04	165	79	4	c746bb22ef52d7f7fa6ee9c37ae6bbe0ccce718e
ToppCell	facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CADM3 CLGN AEBP1 PCOLCE	2.12e-04	165	79	4	f80665b75d43f1bf6919d59fc762e7e0bac653f2
ToppCell	356C-Fibroblasts-Fibroblast-H-\|356C / Donor, Lineage, Cell class and subclass (all cells)	CADM3 AEBP1 PAPPA PCOLCE	2.27e-04	168	79	4	b5d74500bdac0d680ce7eb7afa0b867b8d85e6a4
ToppCell	356C-Fibroblasts-Fibroblast-H\|356C / Donor, Lineage, Cell class and subclass (all cells)	CADM3 AEBP1 PAPPA PCOLCE	2.27e-04	168	79	4	838ce47d4958ba12047882f97925eddd02f081c7
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KIAA1549L AEBP1 CNTN6 PCOLCE	2.27e-04	168	79	4	d2b91f2adc95dcfa623f8d7ca2df1c6f884da988
ToppCell	Immune_cells-Neutrophils\|Immune_cells / Lineage and Cell class	LTA4H MMP9 LCP1 PLSCR1	2.27e-04	168	79	4	3539f802fe0143da1462df0618f78f9f15143f71
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NAALAD2 MCAM GJC1 PCOLCE	2.37e-04	170	79	4	1f994b690e881106a5d54b3080ccce6260bc3ac5
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	UNC13B PTPRM EPAS1 CNTN6	2.37e-04	170	79	4	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	Pericytes-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	NPHS1 KIAA1549L AEBP1 BCHE	2.42e-04	171	79	4	bbc8d9fc83d37c9250345b1e76776610799de9ae
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	AEBP1 BCHE EPAS1 VCPIP1	2.53e-04	173	79	4	3001dd39244ef0a5a475d569a78f4ae427a55db6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	AEBP1 BCHE EPAS1 VCPIP1	2.53e-04	173	79	4	c88883fb2a33e21d4201aa393674aa3f2ad780c9
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NPHS1 IGKV4-1 IGLV5-48 IGLV5-45	2.53e-04	173	79	4	7e6bfe85f60834f317941b70d6e0dc3bd527d293
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	KALRN ACHE MCAM GJC1	2.53e-04	173	79	4	5416b092321c7d9b63f0418c60f2402a138355bf
ToppCell	primary_visual_cortex-Non-neuronal-leptomeningeal_cell\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	AEBP1 LAMA1 PLSCR1 PCOLCE	2.59e-04	174	79	4	2891ab2fd05eb4bbd239d1a2865f21ef7f2df39e
Drug	CHEBI:38548	FOXL2 ACHE BCHE	1.98e-06	8	76	3	CID016126809
Drug	bacoside A	ACHE BCHE MMP9	4.22e-06	10	76	3	ctd:C500175
Drug	ampal	ACHE BCHE ALDH7A1	5.79e-06	11	76	3	CID000129385
Drug	triazophos	ACHE BCHE LCP1	7.69e-06	12	76	3	CID000032184
Drug	NBD-AP-MPF	ACHE BCHE	1.10e-05	2	76	2	CID000124804
Drug	ebeinine	ACHE BCHE	1.10e-05	2	76	2	CID003339043
Drug	AC1OBK56	ACHE BCHE	1.10e-05	2	76	2	CID006849545
Drug	Pyridostigmine	ACHE BCHE	1.10e-05	2	76	2	DB00545
Drug	Fordimine	ACHE BCHE	1.10e-05	2	76	2	CID000003631
Drug	methyl demeton	ACHE BCHE	1.10e-05	2	76	2	ctd:C026086
Drug	aminostigmine	ACHE BCHE	1.10e-05	2	76	2	CID000049113
Drug	N-methylindoxyl acetate	ACHE BCHE	1.10e-05	2	76	2	CID000076747
Drug	EGYT-2347	ACHE BCHE	1.10e-05	2	76	2	CID000172465
Drug	hippadine	ACHE BCHE	1.10e-05	2	76	2	CID000100605
Drug	acetylmonoethylcholine	ACHE BCHE	1.10e-05	2	76	2	CID003016222
Drug	Tacrine	ACHE BCHE	1.10e-05	2	76	2	DB00382
Drug	Methylphosphinic Acid	ACHE BCHE	1.10e-05	2	76	2	DB02845
Drug	4-amino-3-pyridinol	ACHE BCHE	1.10e-05	2	76	2	CID002762419
Drug	2-decanol	ACHE BCHE	1.10e-05	2	76	2	CID000014254
Drug	phosphoramidothiolate	ACHE BCHE	1.10e-05	2	76	2	CID000160999
Drug	ethylparaoxon	ACHE BCHE	1.10e-05	2	76	2	ctd:C121104
Drug	trichloromethyl sulfone	ACHE BCHE	1.10e-05	2	76	2	CID000062478
Drug	furfuryl acetate	ACHE BCHE	1.10e-05	2	76	2	CID000012170
Drug	phosphoryl chloride	ACHE BCHE	1.10e-05	2	76	2	ctd:C013196
Drug	m-(N,N,N-trimethylammonio)trifluoroacetophenone	ACHE BCHE	1.10e-05	2	76	2	ctd:C111602
Drug	melochinine	ACHE BCHE	1.10e-05	2	76	2	CID000134300
Drug	decahydro-2-naphthyl-N-n-butylcarbamate	ACHE BCHE	1.10e-05	2	76	2	ctd:C570679
Drug	S-methylfenitrothion	ACHE BCHE	1.10e-05	2	76	2	CID000018763
Drug	Cholinesterase Reactivators	ACHE BCHE	1.10e-05	2	76	2	ctd:D002801
Drug	P10358	ACHE BCHE	1.10e-05	2	76	2	CID003075612
Drug	xanthostigmine	ACHE BCHE	1.10e-05	2	76	2	CID010765787
Drug	Ro2-0683	ACHE BCHE	1.10e-05	2	76	2	CID000164903
Drug	dihydroatisine	ACHE BCHE	1.10e-05	2	76	2	CID000245004
Drug	lythidathion	ACHE BCHE	1.10e-05	2	76	2	CID000017580
Drug	G 3063	ACHE BCHE	1.10e-05	2	76	2	CID000164899
Drug	demeton-S-methyl	ACHE BCHE	1.10e-05	2	76	2	ctd:C030064
Drug	ethephon	ACHE BCHE	1.10e-05	2	76	2	ctd:C005073
Drug	AC1NAKJK	ACHE BCHE	1.10e-05	2	76	2	CID004478471
Drug	AC1LAYF4	ACHE BCHE	1.10e-05	2	76	2	CID000498098
Drug	GT-165	ACHE BCHE	1.10e-05	2	76	2	CID000189936
Drug	Rivastigmine	ACHE BCHE	1.10e-05	2	76	2	DB00989
Drug	butanediol-divinylether	ACHE BCHE	1.10e-05	2	76	2	CID000077501
Drug	chlorthiophos	ACHE BCHE	1.10e-05	2	76	2	CID000030859
Drug	Demecarium	ACHE BCHE	1.10e-05	2	76	2	DB00944
Drug	famphur	ACHE BCHE	1.10e-05	2	76	2	CID000005859
Drug	eseroline salicylate	ACHE BCHE	1.10e-05	2	76	2	CID003085424
Drug	3-methylbicyclo[3.3.1]non-3-ene	ACHE BCHE	1.10e-05	2	76	2	CID012424180
Drug	pyridoxaloxime	ACHE BCHE	1.10e-05	2	76	2	ctd:C028073
Drug	NSC 90576	ACHE BCHE	1.10e-05	2	76	2	CID000090633
Drug	1,6-dihydroxy-5-methoxyxanthone	ACHE BCHE	1.10e-05	2	76	2	CID005481840
Drug	NSC716725	ACHE BCHE	1.10e-05	2	76	2	CID000402595
Drug	coumarin 106	ACHE BCHE	1.10e-05	2	76	2	CID000100336
Drug	ferrocene carbamate	ACHE BCHE	1.10e-05	2	76	2	CID000160071
Drug	cyanthoate	ACHE BCHE	1.10e-05	2	76	2	CID000077322
Drug	Pralidoxime	ACHE BCHE	1.10e-05	2	76	2	DB00733
Drug	(1S,3R,5S,9E)-9-ethylidene-2,2,7-trimethyl-N3-[7-(1,2,3,4-tetrahydroacridin-9-ylamino)heptyl]bicyclo[3.3.1]non-7-ene-3,5-diamine	ACHE BCHE	1.10e-05	2	76	2	CID011642061
Drug	13-Epilycopodine	ACHE BCHE	1.10e-05	2	76	2	CID000605459
Drug	RS194B	ACHE BCHE	1.10e-05	2	76	2	ctd:C572498
Drug	Isoflurophate	ACHE BCHE	1.10e-05	2	76	2	DB00677
Drug	methyl (1R,5S,7S,9E)-9-ethylidene-3-methyl-7-[7-(1,2,3,4-tetrahydroacridin-9-ylamino)heptylamino]bicyclo[3.3.1]non-2-ene-5-carboxylate	ACHE BCHE	1.10e-05	2	76	2	CID011642248
Drug	Fyrol 6	ACHE BCHE	1.10e-05	2	76	2	CID000017722
Drug	AC1OCFDY	ACHE BCHE	1.10e-05	2	76	2	CID000178654
Drug	AC1LD65U	ACHE BCHE	1.10e-05	2	76	2	CID000612746
Drug	macluraxanthone C	ACHE BCHE	1.10e-05	2	76	2	ctd:C419729
Drug	S 27	ACHE BCHE	1.10e-05	2	76	2	CID000167960
Drug	CID5087854	ACHE BCHE	1.10e-05	2	76	2	CID005087854
Drug	CID5087853	ACHE BCHE	1.10e-05	2	76	2	CID005087853
Drug	arpenal	ACHE BCHE	1.10e-05	2	76	2	CID000019152
Drug	AC1L46HS	ACHE BCHE	1.10e-05	2	76	2	CID000201462
Drug	AC1L461Q	ACHE BCHE	1.10e-05	2	76	2	CID000179849
Drug	Prestwick_647	ACHE BCHE	1.10e-05	2	76	2	CID000179850
Drug	bambuterol	ACHE BCHE	1.10e-05	2	76	2	ctd:C047766
Drug	AC1L4Y7F	ACHE BCHE	1.10e-05	2	76	2	CID000166487
Drug	3-Carbamyl-N-allylquinuclidinium bromide	ACHE BCHE	1.10e-05	2	76	2	CID000192717
Drug	HLo 7	ACHE BCHE	1.10e-05	2	76	2	ctd:C058577
Drug	zifrosilone	ACHE BCHE	1.10e-05	2	76	2	CID000060811
Drug	leptophos oxon	ACHE BCHE	1.10e-05	2	76	2	ctd:C008265
Drug	kuscide	ACHE BCHE	1.10e-05	2	76	2	CID000104269
Drug	K117 compound	ACHE BCHE	1.10e-05	2	76	2	ctd:C530923
Drug	K127 compound	ACHE BCHE	1.10e-05	2	76	2	ctd:C530922
Drug	AC1L9CXQ	ACHE BCHE	1.10e-05	2	76	2	CID000442491
Drug	AC1L9CXH	ACHE BCHE	1.10e-05	2	76	2	CID000442488
Drug	AC1L9CX5	ACHE BCHE	1.10e-05	2	76	2	CID000442483
Drug	fawcettimine	ACHE BCHE	1.10e-05	2	76	2	CID000442475
Drug	AC1LCZ7J	ACHE BCHE	1.10e-05	2	76	2	CID000609286
Drug	allanxanthone A	ACHE BCHE	1.10e-05	2	76	2	CID000636851
Drug	3-phospholine	ACHE BCHE	1.10e-05	2	76	2	CID000068052
Drug	isonicotinohydroxamic acid	ACHE BCHE	1.10e-05	2	76	2	CID000072967
Drug	sanguinine	ACHE BCHE	1.10e-05	2	76	2	CID000443722
Drug	AC1MXKSI	ACHE BCHE	1.10e-05	2	76	2	CID003767210
Drug	Ep-Mp	ACHE BCHE	1.10e-05	2	76	2	CID000151144
Drug	AC1LDPPA	ACHE BCHE	1.10e-05	2	76	2	CID000623938
Drug	propyl-paraoxon	ACHE BCHE	1.10e-05	2	76	2	CID000070856
Drug	tebupirimphos	ACHE BCHE	1.10e-05	2	76	2	CID000093516
Drug	4-amino-2-chlorobenzoic acid	ACHE BCHE	1.10e-05	2	76	2	CID000017154
Drug	LG-63	ACHE BCHE	1.10e-05	2	76	2	CID003083816
Drug	Tetraisopropylpyrophosphamide	ACHE BCHE	1.10e-05	2	76	2	ctd:D013770
Drug	diethyxime	ACHE BCHE	1.10e-05	2	76	2	CID006336652
Drug	AC1MS2Q8	ACHE BCHE	1.10e-05	2	76	2	CID003527747
Drug	1 PC	ACHE BCHE	1.10e-05	2	76	2	CID000006143
Disease	obsolete aging, cognition	PRR20C PRR20D PRR20B PRR20E PRR20A	2.73e-10	15	75	5	EFO_0003925, GO_0007568
Disease	t-tau:beta-amyloid 1-42 ratio measurement	PRR20C PRR20D PRR20B PRR20E PRR20A	7.34e-07	66	75	5	EFO_0007708
Disease	mosaic loss of chromosome Y measurement	PRR20C PRR20D PRR20B PRR20E PRR20A	1.92e-06	80	75	5	EFO_0007783
Disease	Tinnitus, wellbeing measurement	PRR20C PRR20D PRR20B PRR20E PRR20A	4.73e-06	96	75	5	EFO_0007869, HP_0000360
Disease	Malignant Granulosa Cell Tumor	FOXL2 DICER1	6.37e-06	2	75	2	C0334401
Disease	leptospirosis (biomarker_via_orthology)	ACHE BCHE	1.91e-05	3	75	2	DOID:2297 (biomarker_via_orthology)
Disease	Organothiophosphate Poisoning	ACHE BCHE	3.81e-05	4	75	2	C3494248
Disease	Organothiophosphonate Poisoning	ACHE BCHE	3.81e-05	4	75	2	C3494247
Disease	Organophosphate poisoning	ACHE BCHE	3.81e-05	4	75	2	C0700359
Disease	Organophosphorus Poisoning	ACHE BCHE	3.81e-05	4	75	2	C0353676
Disease	Granulosa Cell Cancer	FOXL2 DICER1	6.34e-05	5	75	2	C1567257
Disease	chronic mucocutaneous candidiasis (is_implicated_in)	TRAF3IP2 IL17RC	6.34e-05	5	75	2	DOID:2058 (is_implicated_in)
Disease	primary progressive multiple sclerosis (is_marker_for)	BCHE MMP9	9.50e-05	6	75	2	DOID:0050784 (is_marker_for)
Disease	Candidiasis, Chronic Mucocutaneous	TRAF3IP2 IL17RC	9.50e-05	6	75	2	C0006845
Disease	familial hyperlipidemia (is_marker_for)	BCHE MMP9	9.50e-05	6	75	2	DOID:1168 (is_marker_for)
Disease	bacterial meningitis (is_marker_for)	ACHE BCHE	1.33e-04	7	75	2	DOID:9470 (is_marker_for)
Disease	Muscular Dystrophy	ACHE BCHE	1.77e-04	8	75	2	C0026850
Disease	epilepsy (is_implicated_in)	ACHE BCHE	2.27e-04	9	75	2	DOID:1826 (is_implicated_in)
Disease	eye colour measurement	SHISA9 MBTPS1 PTPRM MYCBP2 CNTN6	2.38e-04	218	75	5	EFO_0009764
Disease	hypertension (is_marker_for)	PAPPA BCHE MMP9	3.37e-04	53	75	3	DOID:10763 (is_marker_for)
Disease	Huntington's disease (is_marker_for)	ACHE BCHE HTT	3.37e-04	53	75	3	DOID:12858 (is_marker_for)
Disease	integral membrane protein 2B measurement	BCHE LCP1	4.14e-04	12	75	2	EFO_0802634
Disease	membranous glomerulonephritis (biomarker_via_orthology)	NPHS1 MMP9	5.69e-04	14	75	2	DOID:10976 (biomarker_via_orthology)
Disease	cerebellum cortex volume change measurement	PTPRM EPAS1	5.69e-04	14	75	2	EFO_0021497
Disease	Hermansky-Pudlak syndrome (implicated_via_orthology)	CCZ1B CCZ1	5.69e-04	14	75	2	DOID:3753 (implicated_via_orthology)
Disease	idiopathic scoliosis (implicated_via_orthology)	MBTPS1 DNAH10	7.48e-04	16	75	2	DOID:0060250 (implicated_via_orthology)
Disease	Rolandic epilepsy	KALRN PTPRM	7.48e-04	16	75	2	Orphanet_1945
Disease	nephrotic syndrome	NPHS1 CCDC66 KALRN	7.96e-04	71	75	3	EFO_0004255
Disease	epilepsy (implicated_via_orthology)	UNC13B NRCAM KALRN ALDH7A1	8.04e-04	163	75	4	DOID:1826 (implicated_via_orthology)
Disease	thrombomodulin measurement	NPHS1 LAMA1	8.46e-04	17	75	2	EFO_0007774
Disease	glucose homeostasis measurement, acute insulin response measurement	SDK2 PTPRM	9.50e-04	18	75	2	EFO_0006831, EFO_0006896
Disease	telomere length	PRR20C PRR20D PRR20B PRR20E PRR20A	1.22e-03	313	75	5	EFO_0004505
Disease	hyperglycemia (biomarker_via_orthology)	MMP9 EPAS1	1.30e-03	21	75	2	DOID:4195 (biomarker_via_orthology)
Disease	Etat Marbre	ACHE HTT	1.56e-03	23	75	2	C0266487
Disease	blood chromium measurement	KIAA1549L PTPRM	1.99e-03	26	75	2	EFO_0007579
Disease	coronary artery disease (is_implicated_in)	KALRN BCHE MMP9	2.14e-03	100	75	3	DOID:3393 (is_implicated_in)
Disease	retinitis pigmentosa (implicated_via_orthology)	CCDC66 PRPF8	2.15e-03	27	75	2	DOID:10584 (implicated_via_orthology)
Disease	primary biliary cholangitis (biomarker_via_orthology)	DAG1 MMP9	2.31e-03	28	75	2	DOID:12236 (biomarker_via_orthology)
Disease	Movement Disorders	ACHE HTT	2.48e-03	29	75	2	C0026650

Protein segments in the cluster

Peptide	Gene	Start	Entry
PKAPQWPPYTAGAQQ	ACHE	526	P22303
AYGKAILPPSQPWAT	EPAS1	426	Q99814
LYLNVWIPAPKPKNA	BCHE	121	P06276
PPPWVQLQLSSAYGA	LINC00588	86	Q9Y4M8
NPWDPNVLYGPLHTK	ALDH7A1	361	P49419
KWVPYRVPNNNLPIP	AEBP1	716	Q8IUX7
ADLWPAKQYPLVTPN	COPB2	816	P35606
VPQQYLWEKEGSVPP	CADM3	261	Q8N126
PPVNWLPPGYVVNQD	DICER1	1376	Q9UPY3
EGFPNLYPPNKECIW	PCOLCE	51	Q15113
IPLTAPPTNQWYHGK	RASA1	171	P20936
NAWLYSPGLPPIKPN	LTA4H	446	P09960
IQPPPLAYKKWGLQD	RAB3GAP2	246	Q9H2M9
QGPFLIADKWPALPR	MMP9	551	P14780
NVKYPAQKLWIEGPP	NPHS1	436	O60500
LQTAGWPPVQLPYLA	LLGL2	366	Q6P1M3
PVGWCQLTGYQLQPP	MBTD1	546	Q05BQ5
GRIVDKPDWQPYLPQ	MBTPS1	526	Q14703
PYWITAPQNLVLSPG	NRCAM	361	Q92823
NKSLAAGVWEYPPNP	GPBP1	151	Q86WP2
PKSLPYVLPWKNNGN	GTSF1	151	Q8WW33
GYPVVGWHIANKKPP	DAG1	291	Q14118
PVDWNRVNKPPYPKL	LCP1	436	P13796
QPVYNQPVGAAGVPW	PLSCR1	71	O15162
DWAKPGPYDQPLVNT	MTSS1	411	O43312
PPKYLQSGFLNNSWP	FOXL2	191	P58012
PWLQPHNGSYSKIPL	KALRN	2936	O60229
VPPGPYRATKLWNEV	DEPDC1	6	Q5TB30
AIALPPIAKWPYQNG	LRBA	216	P50851
GYALWPEQGPPQLVQ	LMLN2	161	A0A1B0GTW7
VLASPWNPQPAGYFQ	KIAA1549L	926	Q6ZVL6
WNPQPAGYFQLKTVL	KIAA1549L	931	Q6ZVL6
LVYQGWQPSRKPAPV	PAPPA	661	Q13219
APPIYQLNAPWLKGQ	IMPACT	66	Q9P2X3
GPQAVDWQPVLTLYP	PRR20D	171	P86480
GPQAVDWQPVLTLYP	PRR20A	171	P86496
GPQAVDWQPVLTLYP	PRR20B	171	P86481
QPELPAEPAAYWSKL	HTT	2191	P42858
VKPPQNLWEYKAVNP	BFAR	251	Q9NZS9
IALDNPYPNPAPQWL	DNAH3	3401	Q8TD57
WNTPSAPPGYNIAVK	GJC1	281	P36383
GPWAAQEKQFPPALL	CCZ1	11	P86791
WVNPNIVYPPGKLEV	FOXR1	56	Q6PIV2
PIYQRKPFIAAWNAP	HYAL4	41	Q2M3T9
PDWNINKPPKRYIPA	CCDC66	701	A2RUB6
GPWAAQEKQFPPALL	CCZ1B	11	P86790
NLAKGQLIFYAPPEW	CNTN6	306	Q9UQ52
YWNGVAVFPKPPQDG	MAN2B2	231	Q9Y2E5
WYQQKPGQPPKLLIY	IGKV4-1	61	P06312
YWNIGPQKTLYLPGP	GLB1L2	586	Q8IW92
WANPGELPGQLPTLY	DNAH10	2381	Q8IVF4
KALAKNNPGWVYIPP	SDS	121	P20132
WQPPAAPNGIILAYQ	SDK2	1321	Q58EX2
PWDQFAPPALALLQG	SBK3	271	P0C264
LSLYWNQVQGPPKPR	IL17RC	306	Q8NAC3
VYVKVNNGPLGNPIW	PTPRM	116	P28827
QFVLLGFPGPWKIQI	OR11H7	11	Q8NGC8
GYPIPQVIWYKNGRP	MCAM	166	P43121
WYQQKPGSPPRYLLN	IGLV5-48	56	A0A075B6I7
NWPGVIRVPAPCQYA	PIWIL1	821	Q96J94
PPPGVNICDVNWKDY	SYPL1	91	Q16563
VSVYRPNQLKPPWSN	SLITRK4	46	Q8IW52
QPPGNVYWPLRGKRE	SPAG8	336	Q99932
WYQQKPGSPPQYLLR	IGLV5-45	56	A0A087WSX0
FLPEANLPPPLNWQY	SEC24A	126	O95486
YVIIKAANAPRPGNW	LAMA1	121	P25391
AAIALPPIAKWPYQN	NBEA	241	Q8NFP9
PPIAKWPYQNGFTLN	NBEA	246	Q8NFP9
GPQAVDWQPVLTLYP	PRR20C	171	P86479
GPQAVDWQPVLTLYP	PRR20E	171	P86478
TNYDTPLWLNTGKPP	SHISA9	121	B4DS77
PYWNAKPAPMPNIGS	MYCBP2	1031	O75592
LPLPPGAFSGLWKNQ	ACSS3	506	Q9H6R3
LHPVQKVILNYPSPW	TRAF3IP2	316	O43734
NYQGIWSPRKIPNPD	CLGN	381	O14967
EPPPLLVYKWCQGIN	PRPF8	946	Q6P2Q9
APPWIQPNGYKSIRS	ZNF516	791	Q92618
PDIILQPDVYPGKCW	SUN3	226	Q8TAQ9
LPVLQGQVPEYPAWF	UNC13B	1051	O14795
PPEWLAPGGKLYNLA	VCPIP1	481	Q96JH7
FPWYQQFPGKGPALL	TRAV23DV6	61	A0A075B6W5
VVFWPQSIPYQNLGP	TMEM254	31	Q8TBM7
EAWIPQAGPPELNYG	ZNF449	161	Q6P9G9
LSQPQWPILVKGCPY	ZP4	376	Q12836
PYPKGWNLPGTAAQR	NAALAD2	231	Q9Y3Q0